Clinical trial
Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus…
NCT00023621 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00023621 |
|---|---|
| Title | Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome |
| Official title | A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Celecoxib in Subjects With Basal Cell Nevus Syndrome |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 60 |
| Start date | Feb 1, 2001 |
| Completion | Jul 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: